Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China
· Delayed Price · Currency is CNY 132.50
-1.50 (-1.12%)
Mar 9, 2026, 3:00 PM CST
Beijing Hotgen Biotech Market Cap
Beijing Hotgen Biotech has a market cap or net worth of 11.77 billion as of March 9, 2026. Its market cap has increased by 102.30% in one year.
Market Cap
11.77B
Enterprise Value
10.72B
Revenue
407.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
132.50
Market Cap Chart
Since September 30, 2019, Beijing Hotgen Biotech's market cap has increased from 4.41B to 11.77B, an increase of 166.96%. That is a compound annual growth rate of 16.48%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Olymvax Biopharmaceuticals | 11.58B |
| Hualan Biological Vaccine | 11.55B |
| Staidson (Beijing) BioPharmaceuticals | 12.35B |
| InventisBio | 12.37B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 13.01B |
| Chengzhi | 10.85B |
| HitGen | 10.83B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 10.70B |